The original antigenic sin: overcoming a barrier to flu vaccination

Emory Vaccine Center researchers are exploring ways to overcome the “original antigenic sin”, a process in which the immune system produces the wrong antibodies after it has encountered multiple strains of the same virus.  Using a mouse model, the team has been able to demonstrate that an vaccine adjuvant can be utilized to overcome the “original antigenic sin” with the flu virus.  For more information about the discovery, please visit: http://news.emory.edu/stories/2012/08/flu_vaccines_original_sin/index.html.

 

Leave a Reply

Your email address will not be published.